1. Home
  2. GNTA vs CATO Comparison

GNTA vs CATO Comparison

Compare GNTA & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNTA
  • CATO
  • Stock Information
  • Founded
  • GNTA 2014
  • CATO 1946
  • Country
  • GNTA Italy
  • CATO United States
  • Employees
  • GNTA N/A
  • CATO N/A
  • Industry
  • GNTA Biotechnology: Biological Products (No Diagnostic Substances)
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • GNTA Health Care
  • CATO Consumer Discretionary
  • Exchange
  • GNTA Nasdaq
  • CATO Nasdaq
  • Market Cap
  • GNTA 70.6M
  • CATO 57.6M
  • IPO Year
  • GNTA 2021
  • CATO N/A
  • Fundamental
  • Price
  • GNTA $3.50
  • CATO $2.82
  • Analyst Decision
  • GNTA Strong Buy
  • CATO
  • Analyst Count
  • GNTA 1
  • CATO 0
  • Target Price
  • GNTA $25.00
  • CATO N/A
  • AVG Volume (30 Days)
  • GNTA 4.2K
  • CATO 38.4K
  • Earning Date
  • GNTA 01-01-0001
  • CATO 08-25-2025
  • Dividend Yield
  • GNTA N/A
  • CATO 6.03%
  • EPS Growth
  • GNTA N/A
  • CATO N/A
  • EPS
  • GNTA N/A
  • CATO N/A
  • Revenue
  • GNTA N/A
  • CATO $642,949,000.00
  • Revenue This Year
  • GNTA N/A
  • CATO N/A
  • Revenue Next Year
  • GNTA N/A
  • CATO N/A
  • P/E Ratio
  • GNTA N/A
  • CATO N/A
  • Revenue Growth
  • GNTA N/A
  • CATO N/A
  • 52 Week Low
  • GNTA $2.74
  • CATO $2.19
  • 52 Week High
  • GNTA $7.28
  • CATO $6.70
  • Technical
  • Relative Strength Index (RSI)
  • GNTA 44.28
  • CATO 46.81
  • Support Level
  • GNTA $3.20
  • CATO $2.77
  • Resistance Level
  • GNTA $3.79
  • CATO $2.95
  • Average True Range (ATR)
  • GNTA 0.21
  • CATO 0.20
  • MACD
  • GNTA -0.04
  • CATO -0.01
  • Stochastic Oscillator
  • GNTA 49.40
  • CATO 19.23

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: